Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Newsfile Corp

29 Jul 2026, 12:45 UTC · 4h ago

Sharp Therapeutics Announces Closing of Non-Brokered Private Placement

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
Sharp Therapeutics closed a non-brokered private placement raising C$1,365,000 through the issuance of 1.5 million common shares at C$0.91 per share. — Provides an immediate cash infusion for working capital, reducing near-term liquidity risk for a preclinical-stage company.
+0.30
2
Company Chairman and director William R. Newlin participated in the offering via Newlin Investment Company 1, LLC with a subscription of US$200,000.45. — Insider buying typically signals confidence in the company's valuation and future prospects to external investors.
+0.20
3
The issued common shares are subject to a four-month plus one-day hold period. — While it prevents immediate dilution/selling pressure, it creates a known future date where a block of shares can enter the market.
-0.10

Which stocks this story touches

6 related stories

Sharp Therapeutics Announ… — SHRX +0.40 | NewsImpactScreener